Bafna Pharmaceuticals informs about retirement of independent director

24 Jun 2025 Evaluate

Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, Bafna Pharmaceuticals has informed that Palamadai Krishnan Sundaresan (DIN: 06954189) will be retiring as an Independent Director of the Company upon completion of his first term, with effect from close of business hours on June 24, 2025. Consequently, he will also cease to be the Chairman of the Audit Committee and a Member of the Nomination & Remuneration Committee of the Company. Further, it has informed that due to the change in composition of the Board of Directors, the Board of Directors has re-constituted the composition of the Committees with effect from June 25, 2025, as details enclosed. Notwithstanding the aforesaid retirement of the Independent Director, the composition of the Board and its Committees continues to remain in compliance with the requirements of the applicable laws. The disclosures as required under Regulation 30 of the SEBI (LODR) Regulations, 2015 read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, are provided in Annexure - I.

The above information is a part of company’s filings submitted to BSE.

Bafna Pharma Share Price

149.40 -3.00 (-1.97%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×